Ecolab Q4 sales rise 5% on Food & Beverage unit strength

Reuters
02/10
Ecolab Q4 sales rise 5% on Food & Beverage unit strength

Overview

  • Water solutions firm's Q4 sales rose 5%, slightly beating analyst expectations

  • Adjusted EPS for Q4 beat analyst expectations, rising 15% yr/yr

  • Company expects 2026 adjusted EPS to grow 12% to 15%

Outlook

  • Ecolab expects 2026 adjusted diluted EPS between $8.43 and $8.63, up 12% to 15%

  • Company anticipates 1Q 2026 adjusted diluted EPS between $1.67 and $1.73, up 11% to 15%

  • Ecolab forecasts 2026 organic sales growth of 3% to 4%, accelerating through the year

Result Drivers

  • ORGANIC SALES GROWTH - Ecolab's Q4 results were driven by strong organic sales growth in Food & Beverage, Pest Elimination, and Life Sciences, offsetting challenges in basic industries and Paper

  • OVIVO ACQUISITION - The acquisition of Ovivo Electronics enhanced Ecolab's Global High-Tech business, contributing to Q4 performance

  • PRODUCTIVITY INITIATIVES - One Ecolab productivity initiatives improved operating income margins, contributing to Q4 results

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

Slight Beat*

$4.20 bln

$4.19 bln (16 Analysts)

Q4 Adjusted EPS

Beat

$2.08

$2.07 (21 Analysts)

Q4 EPS

$1.98

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 12 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for Ecolab Inc is $300.00, about 4.1% above its February 9 closing price of $288.16

  • The stock recently traded at 34 times the next 12-month earnings vs. a P/E of 31 three months ago

Press Release: ID:nBw8MnTxXa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10